Historical record - last NADAC effective date: 1/1/2019
Product Information
MEPRON 750 MG/5 ML SUSPENSION is a brand product labeled by GlaxoSmithKline LLC, priced at $6.8952 per ML under NDC 00173066518. Its NADAC has been published 313 times since Nov 28, 2013.
FDA first approved this application on Feb 8, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the atovaquone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
750 mg/5mL
Manufacturer
GlaxoSmithKline LLCNDC
00173066518
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
1/1/2019
Active Ingredients
ATOVAQUONEApproval Type
New Drug (NDA)
FDA Application
NDA020500FDA Approved
2/8/1995
TE Code
AB
On Market Since
2/28/1995
Pharmacological Classes
Price Statistics
The NADAC for MEPRON 750 MG/5 ML SUSPENSION has been published 313 times since Nov 28, 2013, and over the history we have for it it has risen 29.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.8952 per ML |
|---|---|
| All-time high | $6.8952 (Jan 15, 2020) |
| All-time low | $5.3450 (Nov 28, 2013) |
| Median price | $6.3756 |
| Average price | $6.2541 |
| Largest weekly change | +10.0% (Jan 15, 2014) |
| Weeks tracked | 313 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+29.0%
Last surveyed Jan 15, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEPRON 750 MG/5 ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for MEPRON 750 MG/5 ML SUSPENSION, manufactured by GlaxoSmithKline LLC, is $6.8952 per ML (NDC 00173066518), effective Jan 15, 2020.
How has the price of MEPRON 750 MG/5 ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for MEPRON 750 MG/5 ML SUSPENSION has risen 29.0%. It has been tracked across 313 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MEPRON 750 MG/5 ML SUSPENSION?
Since Nov 28, 2013, the NADAC for MEPRON 750 MG/5 ML SUSPENSION has ranged from a low of $5.3450 (Nov 28, 2013) to a high of $6.8952 (Jan 15, 2020), with a median of $6.3756 per ML.
Are there cheaper alternatives to MEPRON 750 MG/5 ML SUSPENSION?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATOVAQUONE 750 MG/5 ML SUSP, is $0.7561 per ML — about 89% below MEPRON 750 MG/5 ML SUSPENSION.
Who manufactures MEPRON 750 MG/5 ML SUSPENSION?
MEPRON 750 MG/5 ML SUSPENSION (NDC 00173066518) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.